Dr. Pertel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
157 Clark Road
Brookline, MA 02445Phone+1 857-756-8287
Summary
- In my role as translational medicine head for respiratory and infectious diseases at the Novartis Institute for BioMedical Research (NIBR), I oversee early clinical development, including first-in-human and proof-of-concept studies, for respiratory diseases and for anti-infective agents related to tropical diseases. I co-chair the decision boards that govern and set the strategy for these portfolios. My team of physicians works closely with both the research and development groups. In addition, I chair the safety board that approves first-in-human studies and enrollment of vulnerable subjects into clinical studies across all therapeutic areas and company divisions. During my career, I have worked in early and late stage drug development, including Phase 1, 2, 3, and 4 studies, supporting marketing efforts by commercial groups, and interacting with regulatory and health authorities.
Education & Training
Northwestern University Graduate SchoolMPH, 2000 - 2003- Northwestern University Feinberg School of MedicineFellowship, virology research, 1992 - 1995
McGaw Medical Center of Northwestern UniversityFellowship, Infectious Disease, 1990 - 1992- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1987 - 1990
- Northwestern University The Feinberg School of MedicineClass of 1987, M.D.
- University of Illinois at Urbana-ChampaignB.S., Psychology, Cum Laude, 1979 - 1983
Certifications & Licensure
CT State Medical License 2004 - 2023
IL State Medical License 1989 - 2023
MA State Medical License 2008 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 52 citationsSequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and ...Philip Giordano, James Song, Peter Pertel, Janet Herrington, Steven F Kowalsky
International Journal of Antimicrobial Agents. 2005-11-01 - 43 citationsThe Value, Qualification, and Regulatory Use of Surrogate End Points in Drug DevelopmentCD Lathia, D Amakye, W Dai, C Girman, S Madani
Clinical Pharmacology and Therapeutics. 2009-07-01 - 83 citationsRandomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.Mark A. Malangoni, James Song, Janet Herrington, Shurjeel Choudhri, Peter Pertel
Annals of Surgery. 2006-08-01
Books/Book Chapters
Professional Memberships
- Fellow
- Infectious Diseases Society of AmericaMember
- American Society of MicrobiologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
